Search results
Results from the WOW.Com Content Network
Coronavirus infections in the Philippines surged past 100,000 Sunday in a troubling milestone after medical groups declared that the country was waging “a losing battle” against the virus and ...
The COVID-19 pandemic in the Philippines was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 . [4] As of February 17, 2025, there have been 4,173,631 [ 1 ] reported cases, and 66,864 [ 1 ] reported deaths, the fifth highest in Southeast Asia , behind Vietnam , Indonesia ...
The COVID-19 pandemic in Central Visayas is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus reached Central Visayas on February 5, 2020, when the first case of the disease was confirmed in Bohol. As of May 2, 2023, there have been 210,549 ...
The COVID-19 pandemic in Metro Manila was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus reached Metro Manila on January 30, 2020, when the first case of COVID-19 in the Philippines was confirmed in Manila. Metro Manila is the worst ...
Get breaking news and the latest headlines on business, entertainment, politics, world news, tech, sports, videos and much more from AOL
MANILA (Reuters) -The Philippines will ban travellers from 19 countries and territories until mid-January as a measure to keep out a new variant of the coronavirus, its transport ministry said on ...
The COVID-19 pandemic in Central Luzon is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus reached Central Luzon on March 9, 2020, when the first case of the disease was confirmed in San Jose del Monte . [ 1 ]
* The annual U.S. COVID-19 vaccine market going forward could be in the range of $5.2 billion to $12.9 billion, depending on the price of shots and who is eligible to receive them, Moderna's chief ...